Innovation Pharmaceuticals Inc.

IPIXOTCHealthcare● Active

$0.00

+$0.00(+0.00%)

Market Cap$155504

P/E Ratio—

52W High$0.05

52W Low$0.00001

Avg Volume113K

Open$0.00

Beta-0.49

Overview

Innovation Pharmaceuticals Inc. (IPIX) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

IPIX · free cash flow · updated Jun 9, 2026

Core FCF metrics

IPIX · FCF · TTM · margin & CAGR

Free cash flow was −$2.2M for FY2023 (fiscal year ending 2023-06-30), up 65.9% year-over-year

FY2023 Free Cash Flow−$2.2M▲ +65.9% YoY

Trailing 12M (TTM)−$2.0Mtrailing 4 quarters sum

FCF Margin——

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 9, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

IPIX · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2023Latest−$2.1M(0M)−$2.2M▲ +65.9%—

FY2022−$6.3M(0M)−$6.4M▲ +33.5%—

FY2021−$9.5M(0M)−$9.6M▼ 125.3%—

FY2020−$4.2M(0M)−$4.2M▲ +33.8%—

FY2019−$6.3M(0M)−$6.4M▲ +52.1%—

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

IPIX · P/FCF · FCF yield · FCF per share

Innovation Pharmaceuticals Inc. (IPIX) reported negative free cash flow of −$0.00B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2023 · 2023-06-30

Cash flow statement summary

IPIX · cash flow statement · operating / investing / financing

For FY2023, Innovation Pharmaceuticals Inc. generated −$2.1M in operating cash flow and spent 0M in capital expenditures, yielding −$2.2M in free cash flow.

Operating Activities

−$2.1M

Cash from core business operations

2023-06-30

Investing Activities

−$0.1M

CapEx, acquisitions & investments

2023-06-30

Financing Activities

−$0.1M

Buybacks, dividends & debt

2023-06-30

FCF FormulaOperating CF (−$2.1M) − |CapEx| (0M) = FCF (−$2.2M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

IPIX vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Innovation Pharmaceuticals Inc.YOU

IPIX

−$2.2M+65.9%—

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Innovation Pharmaceuticals Inc. (IPIX) reported free cash flow of −$2.2M for FY2023 (fiscal year ending 2023-06-30), up 65.9% year-over-year.

Innovation Pharmaceuticals Inc. has reported negative free cash flow in recent periods, indicating capital expenditures have exceeded operating cash flow. Data available for 15 fiscal years.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

IPIX free cash flow · 8 questions

Innovation Pharmaceuticals Inc. free cash flow was −$2.2M for FY2023, up 65.9% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$2.0M.

IPIX free cash flowIPIX FCFIPIX FCF 2023IPIX free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Innovation Pharmaceuticals Inc. · Innovation Pharmaceuticals Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026